TY - JOUR
AU - Oesterle, S., N.
AB - f1 " Correspondence: Dr I. D. Cox, Cardiology Division, Bulfinch 105, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, U.S.A. References 1 Oesterle SN , Reifart N, Hauptmann E, Hayase M, Yeung AC. Percutaneous in situ coronary venous arterialization: report of the first human catheter-based coronary artery bypass. Circulation . 2001 ; 103 : 2539 –2543 2 Oesterle SN , Sanborn TA, Ali N. Percutaneous transmyocardial laser revascularization for severe angina: the PACIFIC randomized trial. Lancet . 2000 ; 356 : 1705 –1710 3 Simons M , Bonow RO, Chronos NA. Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation . 2000 ; 102 : E73 4 Isner JM . Myocardial gene therapy. Nature . 2002 ; 415 : 234 –239 5 Barr E , Carroll J, Kalynych AM. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther . 1994 ; 1 : 51 –58 6 Boekstegers P , von Degenfeld G, Giehrl W. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther . 2000 ; 7 : 232 –240 7 Li JJ , Ueno H, Pan Y. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res . 1995 ; 30 : 97 –105 8 Vale PR , Losordo DW, Tkebuchava T, Chen D, Milliken CE, Isner JM. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol . 1999 ; 34 : 246 –254 9 Sanborn TA , Hackett NR, Lee LY. Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv . 2001 ; 52 : 260 –266 10 Vale PR , Losordo DW, Milliken CE. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation . 2001 ; 103 : 2138 –2143 11 von der Leyen HE , Gibbons GH, Morishita R. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA . 1995 ; 92 : 1137 –1141 12 Kutryk MJ , Foley DP, van den Brand M. Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J Am Coll Cardiol . 2002 ; 39 : 281 –287 13 Kipshidze N , Moses J, Shankar LR, Leon M. Perspectives on antisense therapy for the prevention of restenosis. Curr Opin Mol Ther . 2001 ; 3 : 265 –277 14 Shah AS , Lilly RE, Kypson AP. Intracoronary adenovirus-mediated delivery and overexpression of the beta 2-adrenergic receptor in the heart: prospects for molecular ventricular assistance. Circulation . 2000 ; 101 : 408 –414 15 Weig HJ , Laugwitz KL, Moretti A. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Circulation . 2000 ; 101 : 1578 –1585 16 Miyamoto MI , del Monte F, Schmidt U. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA . 2000 ; 97 : 793 –798 17 Koh GY , Klug MG, Soonpaa MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest . 1993 ; 92 : 1548 –1554 18 Soonpaa MH , Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science . 1994 ; 264 : 98 –101 19 Leor J , Patterson M, Quinones MJ, Kedes LH, Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation . 1996 ; 94 : II332 –6 20 Scorsin M , Hagege AA, Marotte F. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation . 1997 ; 96 : II188 –93 21 Li RK , Mickle DA, Weisel RD. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation . 1997 ; 96 : II179 –86 22 Taylor DA , Atkins BZ, Hungspreugs P. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med . 1998 ; 4 : 929 –933 23 Scorsin M , Hagege A, Vilquin JT. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg . 2000 ; 119 : 1169 –1175 24 Tomita S , Li RK, Weisel RD. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation . 1999 ; 100 : II247 –56 25 Anversa P , Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature . 2002 ; 415 : 240 –243 26 Orlic D , Kajstura J, Jakoniuk I. Bone marrow cells regenerate infarcted myocardium. Nature . 2001 ; 410 : 701 –705 27 Kocher A , Schuster M, Takuma S. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling, and improves cardiac function. Nat Med . 2001 ; 7 : 430 –436 28 Menasche P , Hagege A, Scorsin M. Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case. Arch Mal Coeur Vaiss . 2001 ; 94 : 180 –182 29 Thompson CA , Nasseri BA, Makower J. Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol . 2002 ; 39 : 75A Article PDF first page preview Close This content is only available as a PDF. The European Society of Cardiology
TI - Biointerventional cardiovascular therapy
JF - European Heart Journal
DO - 10.1053/euhj.2002.3321
DA - 2002-11-01
UR - https://www.deepdyve.com/lp/oxford-university-press/biointerventional-cardiovascular-therapy-SPn06MXOE2
SP - 1753
VL - 23
IS - 22
DP - DeepDyve
ER -